Mazdutide for type 2 diabetes with early memory problems
Treatments studied
Part of Blood & lymphatic, Brain & nervous system, Cancer, Hormones & metabolism, Immune system & allergy, Mental health clinical trials.
This study tests a new medication, Mazdutide, to see if it can slow or improve memory and thinking problems in people with type 2 diabetes and early-stage cognitive impairment. It may help by targeting blood sugar control and possibly reducing the impact of diabetes on brain function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes and your blood sugar (HbA1c) is between 7.0 and 9.0%.
- You are between 50 and 75 years old.
- You have mild memory or thinking problems (either mild cognitive impairment or mild dementia) that have been worsening slowly for at least 6 months.
- Your diabetes treatment has been stable for the last 3 months (can be diet-only or with metformin, sulfonylureas, etc., possibly plus a long-acting bedtime insulin).
- You have a body mass index (BMI) of 20 or higher and your weight has been stable for 3 months.
- You are willing to undergo cognitive tests, MRI scans, and follow the study protocol.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational injectable medication (HRS-4729) to see if it can improve blood sugar control in people with type 2 diabetes. It is for patients who are not on many diabetes medications yet, and the trial monitors safety and effectiveness over time.
This study tests if a combination of insulin and semaglutide (a diabetes drug) can improve memory and thinking in people with mild cognitive impairment (MCI) who also have metabolic syndrome (a cluster of health issues like large waist, high blood sugar, and high blood pressure). It aims to see if treating blood sugar problems helps protect the brain.
This study is looking at ways to catch early thinking and memory changes in people with type 2 diabetes. By joining, you may help doctors learn how to spot problems sooner and find better ways to help.
This study screens older adults with type 2 diabetes for early signs of memory or thinking problems, and offers a program to help keep the brain healthy. It aims to find out if a combination of lifestyle changes, mental exercises, and medical support can slow cognitive decline.
This study looks at whether exercise and a diabetes medication (semaglutide) can improve brain health in older adults with type 2 diabetes. It may help you think more clearly and manage your blood sugar better.
This trial tests a new medicine called mazdutide to see if it can help people with type 2 diabetes achieve remission (return to normal blood sugar levels without needing medicine). It's a placebo-controlled study, meaning some participants will get the real drug and others will get a fake one, to compare results. You must be within 5 years of diagnosis and have a BMI over 24.
Hear when a new Dementia, Mild trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.